title: Intravitreal cysticercosis presenting as neovascular glaucoma.
abstract: We report two cases of intraocular cysticercosis which showed a peculiar presentation of neovascular glaucoma which is hitherto unreported. Two young adults presented with symptoms of raised intraocular pressure due to neovascular glaucoma. On dilated fundus examination both were found to have dead intravitreal cysticercosis. The cysts were removed by a three-port vitrectomy and intracameral injection of bevacizumab was given to help in the regression of rubeosis. Trabeculectomy had to be combined in one case. The intraocular pressure returned to normal. No recurrence of rubeosis was seen even after one year.
authors.affiliation: Bhagawan Mahavir Vitreoretinal Services and Department of Glaucoma, Sankara Nethralaya, Chennai, India.
authors.forename: Dhanashree
authors.initials: D
authors.lastname: Ratra
authors.forename: Chekitaan
authors.initials: C
authors.lastname: Phogat
authors.forename: Maneesh
authors.initials: M
authors.lastname: Singh
authors.forename: Nikhil S
authors.initials: NS
authors.lastname: Choudhari
mesh_terms: D000293:Adolescent; D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000959:Antihypertensive Agents / Q000008:administration & dosage; D000068258:Bevacizumab; D003551:Cysticercosis / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D003552:Cysticercus / Q000302:isolation & purification*; D003937:Diagnosis, Differential; D015822:Eye Infections, Parasitic / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D015355:Glaucoma, Neovascular / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D006068:Gonioscopy; D006801:Humans; D007267:Injections; D007429:Intraocular Pressure; D008297:Male; D009883:Ophthalmic Solutions; D014821:Vitrectomy; D014822:Vitreous Body / Q000469:parasitology* / Q000473:pathology / Q000601:surgery
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000959:Antihypertensive Agents; D009883:Ophthalmic Solutions; D000068258:Bevacizumab